[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100530785":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":29,"centralContacts":37,"locations":46,"responsibleParty":65,"collaborators":10,"id":68,"slug":69,"hasResults":70,"nctId":71,"briefTitle":72,"officialTitle":73,"acronym":10,"eligibilityCriteria":74,"healthyVolunteers":75,"sex":76,"minAge":77,"maxAge":10,"enrollmentInfo":78,"targetDuration":10,"studyType":81,"phases":10,"briefSummary":82,"conditions":83,"keywords":86,"overallStatus":49,"whyStopped":10,"lastUpdateSubmitDate":91,"lastUpdatePostDateStruct":92,"startDateStruct":95,"completionDateStruct":97,"leadSponsor":99,"locationsCount":100},{"fullName":5,"class":6},"Hvidovre University Hospital","OTHER",[8,15],{"label":9,"type":10,"description":11,"interventionNames":12},"SARS-CoV-2 positive patients",null,"a cohort of former patients hospitalized with COVID-19",[13,14],"Procedure: blood sample","Other: Online questionaire",{"label":16,"type":10,"description":17,"interventionNames":18},"SARS-CoV-2 negative patients","a control group of former patients hospitalized with other respiratory diseases",[13,14],[20,25],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":10},"PROCEDURE","blood sample","Blood sample collected in the post-acute period (follow-up visit) will be analysed for biomarkers predictive for diseases related to and disease progression in various organ systems (e.g., cardiovascular, pulmonary, and renal systems), including e.g., Pro-BNP, NGAL, and interleukins.",[16,9],{"type":6,"name":26,"description":27,"armGroupLabels":28,"otherNames":10},"Online questionaire","The participants will complete an online questionnaire related to disease and health issues associated with COVID-19 and COVID-19 post-acute sequalae's and existing Non-Communicable Disease.",[16,9],[30,34],{"name":31,"affiliation":32,"role":33},"Ove Andersen, Professor","Department of Clinical Research, Copenhagen University Hospital, Hvidovre","PRINCIPAL_INVESTIGATOR",{"name":35,"affiliation":32,"role":36},"Jon Ambaek Durhuus, PhD","STUDY_CHAIR",[38,42],{"name":31,"role":39,"phone":40,"phoneExt":10,"email":41},"CONTACT","+4529333262","ove.andersen@regionh.dk",{"name":43,"role":39,"phone":44,"phoneExt":10,"email":45},"Mette Bendtz Lindstroem, MPH","+4538623308","mlin0062@regionh.dk",[47],{"facility":48,"status":49,"city":50,"state":10,"zip":51,"country":52,"countryCode":53,"cosmosGeoPoint":54,"geoPoint":59,"contacts":60},"Copenhagen University Hospital, Amager and Hvidovre","RECRUITING","Hvidovre","2650","Denmark","DK",{"type":55,"coordinates":56},"Point",[57,58],12.47708,55.64297,{"lat":58,"lon":57},[61,62,64],{"name":31,"role":39,"phone":40,"phoneExt":10,"email":41},{"name":63,"role":39,"phone":44,"phoneExt":10,"email":45},"Mette Lindstroem, MPH",{"name":31,"role":33,"phone":10,"phoneExt":10,"email":10},{"type":33,"investigatorFullName":66,"investigatorTitle":67,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Ove Andersen","Research Director, professor,","100530785","post-acute-covid-19-sequelae-in-denmark-100530785",false,"NCT06191302","Post-acute COVID-19 Sequelae in Denmark","Investigation of COVID-19 Post-acute Sequelae in Patients From Hvidovre Hospitals Catchment Area, and in a Register of the Danish Population 2000-2026","Inclusion Criteria:\n\n* Has a blood sample in the clinical biobank related to the OBS-COVID index admission\n* Aged above 18 years at time of index-admission\n\nExclusion Criteria:\n\n* Patients without a Danish personal identification number\n* Patients who do not understand or speak Danish",true,"ALL","18 Years",{"count":79,"type":80},800,"ESTIMATED","OBSERVATIONAL","Since the first SARS-CoV-2 cases in 2019, over 660 million COVID-19 cases have been reported globally, including 183 million in the EU. Up to 70% of those infected experience reduced organ function four months or more after a COVID-19 diagnosis, potentially increasing the risk of non-communicable diseases (NCDs). The post-acute phase (PAP) after COVID-19 (four months or more after the acute phase) can lead to impaired function in various organ systems, with a focus on the lungs, cardiovascular system, and kidneys. These three NCDs collectively impose a significant burden on individuals and society. Urgently, we need to understand the connection between COVID-19, PAP and NCDs, identifying robust biomarkers for early detection. This study examines PAP and associated risk factors, investigating the link between PAP and the heightened risk of lung, heart, and kidney complications. Utilizing data from a cohort of COVID-19 patients and a control group with respiratory diseases, the study aims to determine prevalence and risk ratios more precisely. The aim is to contribute to minimizing the risk of NCD development or exacerbation in current and future COVID-19 patients, enhancing our understanding of chronic disease development at the population leve",[84,85],"Non-communicable Disease","COVID-19",[87,88,89,90],"Sequelae","Inflammation","Ageing","Non-communicable disease","2025-03-06",{"date":93,"type":94},"2025-03-12","ACTUAL",{"date":96,"type":94},"2024-09-10",{"date":98,"type":80},"2026-03-01",{"name":5,"class":6},1]